Omeprazole/amoxicillin/rifabutin

Omeprazole/amoxicillin/rifabutin, sold under the brand name Talicia, is a fixed-dose combination medication used for the treatment of Helicobacter pylori infection.^[1] It is taken by mouth.^[1]

Omeprazole/amoxicillin/rifabutin

Combination of
Omeprazole	Proton-pump inhibitor
Amoxicillin	Penicillin-class antibacterial
Rifabutin	Rifamycin antibacterial
Clinical data
Trade names	Talicia
AHFS/Drugs.com	Professional Drug Facts
License data	US DailyMed: Omeprazole_magnesium,_amoxicillin_and_rifabutin
Routes of administration	By mouth
ATC code	A02BD16 (WHO)
Legal status
Legal status	US: ℞-only[1]
Identifiers
KEGG	D11858

It was approved for medical use in the United States in November 2019.^[2]